Our previous study has shown that lymphocyte counts did not differ significantly between survivors and non-survivors in non-HIV PJP, whereas NLR demonstrated stronger prognostic performance, even surpassing CD4+ T cell count in predictive accuracy [5]. This evidence concerns the gene CD4 and pneumocystosis.